Boxer Capital’s Million Corvus Bet Signals Confidence
Boxer Capital quietly boosted its stake in Corvus Pharmaceuticals, a move that signals institutional faith in the bio...
Innovative Skincare Clinical
Innovative Skincare Clinical presents study results and product evaluations to help you assess effectiveness and safety in modern skincare.
1,157 articlesInmune (INMB) 2025 Earnings Outlook for Investors
Biotech investing hinges on milestones and discipline. This article breaks down inmune (INMB) 2025 earnings, what the...
CytomX (CTMX) 2025 Earnings Outlook for Investors Worldwide
CytomX sits at a crossroads as 2025 earnings unfold, with pipeline updates, collaboration deals, and cost discipline ...
Here's Grail Stock Soared: What Drove the May Rally and Where It's Heading
In May, Grail stock surged on optimism about FDA approval timing and potential reimbursement for the Galleri MCED tes...
Viking Therapeutics Stock No-Brainer: Is It Worth Buying Below $35?
Viking Therapeutics trades around the low $30s as pivotal data for VK2735 approaches. This article breaks down whethe...
HeartFlow NovoCure: Which Emerging Stock Is Best in 2026
HeartFlow and NovoCure represent two very different paths to modernizing care. One targets non invasive CAD diagnosis...
How Much Could $1,000 Invested in Viking Grow by 2030?
Investing in biotech can be bold. This piece lays out practical scenarios for what much could $1,000 invested in Viki...
Taysha's Chief Sold $1.2: What It Means for Investors
An insider move at a biotech stage company can spark questions. This article breaks down the trade, its timing, and w...
Biotech Fund Doubles Down: Scholar Rock Bet Drives 26% Rally
A major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
Acuta Capital Erasca Bets Big on Targeted Cancer Therapies
A niche investment move places acuta capital erasca (eras) at the center of Erasca's ambitious quest in targeted canc...
Why This Fund Just Made a $55 Million Bet on Dianthus
A prominent fund has poured roughly $55 million into Dianthus as the stock climbs 350%. This article breaks down what...
This Beaten-Down Growth Stock Could Jump 30%, According to Wall Street
A high-flying biotech spin-off has faced a brutal disconnect between hype and reality. This beaten-down growth stock ...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Crypto For Beginners
Best Dividend Etfs
Index
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Time To Notice Score Change After Secured Card
Secured Card Reported To Credit Bureaus Instantly
Secured Card Immediate Impact On Credit Score